| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3730188
[patent_doc_number] => 05665577
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-09
[patent_title] => 'Vectors containing HIV packaging sequences, packaging defective HIV vectors, and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/152902
[patent_app_country] => US
[patent_app_date] => 1993-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8163
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/665/05665577.pdf
[firstpage_image] =>[orig_patent_app_number] => 152902
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/152902 | Vectors containing HIV packaging sequences, packaging defective HIV vectors, and uses thereof | Nov 14, 1993 | Issued |
| 08/150475 | METHOD OF TREATMENT USING, PROCESS OF PREPARING, AND COMPOSITION COMPRISING A RECOMBINANT HSV-1 VIRUS | Nov 9, 1993 | Abandoned |
Array
(
[id] => 3486933
[patent_doc_number] => 05474935
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-12-12
[patent_title] => 'Adeno-associated virus (AAV)-based eucaryotic vectors'
[patent_app_type] => 1
[patent_app_number] => 8/145306
[patent_app_country] => US
[patent_app_date] => 1993-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 32
[patent_no_of_words] => 9846
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/474/05474935.pdf
[firstpage_image] =>[orig_patent_app_number] => 145306
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/145306 | Adeno-associated virus (AAV)-based eucaryotic vectors | Nov 2, 1993 | Issued |
| 08/139994 | RECOMBINANT RETROVIRUSES | Oct 19, 1993 | Abandoned |
Array
(
[id] => 3722268
[patent_doc_number] => 05672493
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-30
[patent_title] => 'De novo induction of cells exhibiting characteristics of macrophages utilizing feline sarcoma virus'
[patent_app_type] => 1
[patent_app_number] => 8/135390
[patent_app_country] => US
[patent_app_date] => 1993-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7631
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/672/05672493.pdf
[firstpage_image] =>[orig_patent_app_number] => 135390
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/135390 | De novo induction of cells exhibiting characteristics of macrophages utilizing feline sarcoma virus | Oct 7, 1993 | Issued |
Array
(
[id] => 3742368
[patent_doc_number] => 05801056
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-01
[patent_title] => 'Nucleic acid encoding HIV-1 tat protein'
[patent_app_type] => 1
[patent_app_number] => 8/131898
[patent_app_country] => US
[patent_app_date] => 1993-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 14
[patent_no_of_words] => 7576
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/801/05801056.pdf
[firstpage_image] =>[orig_patent_app_number] => 131898
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/131898 | Nucleic acid encoding HIV-1 tat protein | Oct 4, 1993 | Issued |
| 08/124962 | NON-HUMAN IMMUNOCOMPETENT ANIMAL MODEL | Sep 20, 1993 | Abandoned |
Array
(
[id] => 3622217
[patent_doc_number] => 05593972
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-01-14
[patent_title] => 'Genetic immunization'
[patent_app_type] => 1
[patent_app_number] => 8/125012
[patent_app_country] => US
[patent_app_date] => 1993-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 23
[patent_no_of_words] => 30633
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/593/05593972.pdf
[firstpage_image] =>[orig_patent_app_number] => 125012
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/125012 | Genetic immunization | Sep 20, 1993 | Issued |
Array
(
[id] => 3981983
[patent_doc_number] => 05861282
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-19
[patent_title] => 'Non-infectious HIV particles and uses therefor'
[patent_app_type] => 1
[patent_app_number] => 8/117981
[patent_app_country] => US
[patent_app_date] => 1993-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 18
[patent_no_of_words] => 9525
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/861/05861282.pdf
[firstpage_image] =>[orig_patent_app_number] => 117981
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/117981 | Non-infectious HIV particles and uses therefor | Sep 6, 1993 | Issued |
| 08/114288 | VIRAL PARTICLES HAVING ALTERED HOST RANGE | Aug 29, 1993 | Abandoned |
| 08/106209 | TRANSGENIC EXPRESSION OF GROWTH ASSOCIATED PROTEIN IN VITRO AND IN VIVO | Aug 12, 1993 | Abandoned |
Array
(
[id] => 3108819
[patent_doc_number] => 05413927
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-05-09
[patent_title] => 'Feline immunodeficiency virus isolate NCSU.sub.1Lb'
[patent_app_type] => 1
[patent_app_number] => 8/105710
[patent_app_country] => US
[patent_app_date] => 1993-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 11365
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/413/05413927.pdf
[firstpage_image] =>[orig_patent_app_number] => 105710
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/105710 | Feline immunodeficiency virus isolate NCSU.sub.1Lb | Aug 11, 1993 | Issued |
Array
(
[id] => 3873471
[patent_doc_number] => 05728385
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-17
[patent_title] => 'Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae'
[patent_app_type] => 1
[patent_app_number] => 8/104529
[patent_app_country] => US
[patent_app_date] => 1993-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 23129
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/728/05728385.pdf
[firstpage_image] =>[orig_patent_app_number] => 104529
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/104529 | Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae | Aug 11, 1993 | Issued |
Array
(
[id] => 3487987
[patent_doc_number] => 05470726
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-11-28
[patent_title] => 'Retrovirus packaging and producer cell lines based on gibbon ape leukemia virus'
[patent_app_type] => 1
[patent_app_number] => 8/105471
[patent_app_country] => US
[patent_app_date] => 1993-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6474
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/470/05470726.pdf
[firstpage_image] =>[orig_patent_app_number] => 105471
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/105471 | Retrovirus packaging and producer cell lines based on gibbon ape leukemia virus | Aug 10, 1993 | Issued |
Array
(
[id] => 3512808
[patent_doc_number] => 05512421
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-04-30
[patent_title] => 'Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors'
[patent_app_type] => 1
[patent_app_number] => 8/104804
[patent_app_country] => US
[patent_app_date] => 1993-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 21533
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/512/05512421.pdf
[firstpage_image] =>[orig_patent_app_number] => 104804
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/104804 | Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors | Aug 9, 1993 | Issued |
| 08/103401 | METHODS FOR EX VIVO THERAPY USING PEPTIDE-LOADED ANTIGEN PRESENTING CELLS FOR THE ACTIVATION OF CTL | Aug 5, 1993 | Abandoned |
| 08/099870 | INTRACELLULAR IMMUNIZATION | Jul 29, 1993 | Pending |
| 08/093210 | REDIRECTION OF CELLULAR IMMUNITY BY RECEPTOR CHIMERAS | Jul 15, 1993 | Pending |
| 08/093235 | DELIVERY OF GENETIC MATERIAL BY NEEDLELESS INJECTION DEVICES | Jul 14, 1993 | Pending |
Array
(
[id] => 3888574
[patent_doc_number] => 05723588
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-03
[patent_title] => 'Protein-enriched thermoplastics'
[patent_app_type] => 1
[patent_app_number] => 8/089862
[patent_app_country] => US
[patent_app_date] => 1993-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 21313
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/723/05723588.pdf
[firstpage_image] =>[orig_patent_app_number] => 089862
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/089862 | Protein-enriched thermoplastics | Jul 8, 1993 | Issued |